X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (74174) 74174
Book Review (11267) 11267
Publication (5602) 5602
Newsletter (2101) 2101
Newspaper Article (446) 446
Book Chapter (444) 444
Conference Proceeding (320) 320
Magazine Article (100) 100
Dissertation (71) 71
Transcript (61) 61
Book / eBook (45) 45
Reference (25) 25
Trade Publication Article (19) 19
Paper (7) 7
Web Resource (7) 7
Data Set (3) 3
Journal / eJournal (3) 3
Government Document (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (59251) 59251
humans (57314) 57314
male (26200) 26200
female (25467) 25467
middle aged (20054) 20054
oncology (17810) 17810
aged (17348) 17348
adult (15723) 15723
hematology (15028) 15028
animals (12097) 12097
b-cell lymphoma (10997) 10997
lymphomas (10871) 10871
lymphoma (10091) 10091
cancer (9639) 9639
b cells (8293) 8293
mice (7847) 7847
abridged index medicus (7559) 7559
prognosis (7507) 7507
lymphoma, large b-cell, diffuse - pathology (7124) 7124
immunology (7033) 7033
aged, 80 and over (6830) 6830
expression (6696) 6696
rituximab (6432) 6432
lymphoma, b-cell - pathology (6168) 6168
pathology (6152) 6152
non-hodgkins-lymphoma (6116) 6116
research (5752) 5752
chemotherapy (5663) 5663
antineoplastic combined chemotherapy protocols - therapeutic use (5662) 5662
adolescent (5535) 5535
apoptosis (5481) 5481
treatment outcome (5263) 5263
leukemia (5015) 5015
immunohistochemistry (4673) 4673
lymphoma, large b-cell, diffuse - drug therapy (4434) 4434
b-cells (4234) 4234
lymphocytes b (4213) 4213
child (4175) 4175
care and treatment (4159) 4159
analysis (4027) 4027
diagnosis, differential (3939) 3939
b-lymphocytes - immunology (3879) 3879
gene expression (3873) 3873
hemic and lymphatic diseases (3844) 3844
health aspects (3834) 3834
cell biology (3813) 3813
chronic lymphocytic-leukemia (3793) 3793
survival (3764) 3764
genetic aspects (3633) 3633
diagnosis (3552) 3552
lymphocytes (3548) 3548
flow cytometry (3520) 3520
therapy (3484) 3484
proteins (3451) 3451
lymphoma, large b-cell, diffuse - diagnosis (3416) 3416
retrospective studies (3407) 3407
disease (3317) 3317
cell line, tumor (3276) 3276
leukemia, lymphocytic, chronic, b-cell - pathology (3226) 3226
antineoplastic agents - therapeutic use (3212) 3212
lymphoma, b-cell - genetics (3124) 3124
tumors (3068) 3068
diffuse large b-cell lymphoma (3011) 3011
activation (2920) 2920
mutation (2910) 2910
tumor cells, cultured (2902) 2902
article (2894) 2894
immunophenotyping (2859) 2859
chronic lymphocytic leukemia (2843) 2843
t cells (2829) 2829
medicine, research & experimental (2802) 2802
biopsy (2800) 2800
lymphoma, b-cell - drug therapy (2784) 2784
biochemistry & molecular biology (2772) 2772
non-hodgkin's lymphomas (2742) 2742
lymphoma, large b-cell, diffuse - genetics (2649) 2649
young adult (2627) 2627
leukemia, lymphocytic, chronic, b-cell - drug therapy (2597) 2597
medicine & public health (2575) 2575
signal transduction (2574) 2574
b-cell (2562) 2562
polymerase chain reaction (2552) 2552
neoplasm staging (2546) 2546
lymphoma, b-cell - diagnosis (2526) 2526
risk factors (2508) 2508
immunotherapy (2499) 2499
follicular lymphoma (2494) 2494
leukemia, lymphocytic, chronic, b-cell - genetics (2486) 2486
lymphoma, b-cell - immunology (2471) 2471
child, preschool (2463) 2463
lymphoma, b-cell, marginal zone - pathology (2459) 2459
gene (2334) 2334
genes (2318) 2318
antibodies, monoclonal - therapeutic use (2308) 2308
follow-up studies (2307) 2307
neoplasms (2271) 2271
b-lymphocytes - metabolism (2264) 2264
lymphoma, non-hodgkin - pathology (2263) 2263
classification (2250) 2250
lymphoma, large b-cell, diffuse (2188) 2188
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (69083) 69083
German (1443) 1443
Japanese (1391) 1391
French (1372) 1372
Chinese (985) 985
Spanish (700) 700
Italian (673) 673
Russian (654) 654
Polish (243) 243
Korean (242) 242
Hungarian (89) 89
Czech (88) 88
Portuguese (77) 77
Danish (55) 55
Romanian (55) 55
Dutch (53) 53
Turkish (42) 42
Serbian (28) 28
Croatian (23) 23
Swedish (19) 19
Bulgarian (18) 18
Norwegian (17) 17
Slovak (17) 17
Hebrew (16) 16
Finnish (13) 13
Ukrainian (6) 6
Persian (4) 4
Lithuanian (3) 3
Afrikaans (2) 2
Bosnian (2) 2
Galician (1) 1
Greek (1) 1
Manx (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 89, Issue 1, pp. 49 - 58
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 03/2010, Volume 34, Issue 3, pp. 327 - 340
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements, also known as "double-hit'' lymphomas (DHL), are rare neoplasms characterized by highly... 
BCL2 | Cytogenetics | High-grade B-cell lymphoma | MYC | Burkitt lymphoma | Diffuse large B-cell lymphoma | high-grade B-cell lymphoma | SURGERY | MALIGNANT-LYMPHOMAS | TRANSLOCATIONS | T(14/18) | C-MYC | FOLLICULAR LYMPHOMA | diffuse large B-cell lymphoma | PATHOLOGY | cytogenetics | POLYMERASE-CHAIN-REACTION | POOR-PROGNOSIS | ACUTE LYMPHOBLASTIC-LEUKEMIA | NON-HODGKINS-LYMPHOMA | OF-THE-LITERATURE | Predictive Value of Tests | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Gene Expression Regulation, Neoplastic | Drug Resistance, Neoplasm | Male | Lymphoma, B-Cell - genetics | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Genes, Immunoglobulin Heavy Chain | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Time Factors | Karyotyping | Polymerase Chain Reaction | Aged, 80 and over | Burkitt Lymphoma - genetics | Adult | Female | Retrospective Studies | Child | Burkitt Lymphoma - therapy | Lymphoma, B-Cell - mortality | World Health Organization | Burkitt Lymphoma - classification | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols | Terminology as Topic | Immunophenotyping | In Situ Hybridization, Fluorescence | Treatment Outcome | Lymphoma, B-Cell - classification | Lymphoma, Large B-Cell, Diffuse - mortality | Gene Rearrangement, B-Lymphocyte, Heavy Chain | Lymphoma, Large B-Cell, Diffuse - classification | Adolescent | Lymphoma, B-Cell - pathology | Aged | Proto-Oncogene Proteins c-myc - genetics | Neoplasm Staging | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2015, Volume 168, Issue 6, pp. 806 - 810
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2012, Volume 30, Issue 36, pp. 4462 - 4469
Journal Article
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 04/2016, Volume 134, Issue 4, pp. 406 - 414
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 559 - 564
To the authors' knowledge, the current study is the first large comparative analysis of double‐hit lymphomas by patterns of oncogene rearrangement. Patterns of... 
BCL6 (B‐cell lymphoma 6) | non‐Hodgkin lymphoma | gene rearrangement | BCL2 (B‐cell lymphoma 2) | MYC | BCL6 (B-cell lymphoma 6) | non-Hodgkin lymphoma | BCL2 (B-cell lymphoma 2) | RITUXIMAB PLUS CYCLOPHOSPHAMIDE | TRANSLOCATIONS | IN-VIVO EFFICACY | DOXORUBICIN | B-CELL LYMPHOMA | PREDNISONE | BCL6 | ONCOLOGY | VINCRISTINE | EXPRESSION | Doxorubicin - therapeutic use | Prognosis | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Bone Marrow Neoplasms - genetics | Lymphoma, B-Cell - genetics | Cyclophosphamide - therapeutic use | Lymphoma, Non-Hodgkin - pathology | Burkitt Lymphoma - pathology | Burkitt Lymphoma - genetics | Female | Burkitt Lymphoma - drug therapy | Databases, Factual | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Ifosfamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Central Nervous System Neoplasms - genetics | Etoposide - therapeutic use | Survival Rate | Germinal Center - pathology | Lymphoma, Non-Hodgkin - genetics | DNA-Binding Proteins - genetics | Genes, bcl-2 - genetics | Rituximab - administration & dosage | Central Nervous System Neoplasms - pathology | Dexamethasone - therapeutic use | Bone Marrow Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Genes, myc - genetics | Lymphoma, B-Cell - pathology | Vincristine - therapeutic use | Bone Marrow Neoplasms - drug therapy | Central Nervous System Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Cohort Studies | Proto-Oncogene Proteins c-bcl-6 | Care and treatment | Chemotherapy | Usage | Non-Hodgkin's lymphomas | Diagnosis | Research | Oncogenes | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4212 - 4223
Purpose: Patients with B-cell lymphomas often relapse after frontline therapy, and novel therapies are urgently needed to provide long-term remission. We... 
ONCOLOGY | RITUXIMAB | BONE-MARROW | INVOLVEMENT | IBRUTINIB | RESISTANCE | NON-HODGKIN-LYMPHOMA | CANCER | CHEMOTHERAPY | TRANSPLANTATION | FEATURES | Lymphoma, Follicular - drug therapy | Humans | Lymphoma, Mantle-Cell - pathology | Protein Kinase Inhibitors - adverse effects | Burkitt Lymphoma - pathology | Protein-Tyrosine Kinases - genetics | Lymphoma, Follicular - genetics | Burkitt Lymphoma - genetics | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - genetics | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Precision Medicine | Pyrazoles - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Drug Discovery | Lymphoma, B-Cell, Marginal Zone - genetics | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Lymphoma, B-Cell, Marginal Zone - drug therapy | Lymphoma, Large B-Cell, Diffuse - classification | Pyrimidines - adverse effects | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Cell culture | Therapy | Animal models | Kinases | Inactivation | Signal transduction | Biological effects | Peripheral blood | Xenografts | Remission | Protein-tyrosine kinase | Tyrosine | Deactivation | Tumor cells | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Burkitt's lymphoma | Signaling | Inhibitors | Lymphocytes B | Experimental design | Mantle cell lymphoma | Lymphomas | Mutation | Tumors | Cancer | B-cell lymphoma | Index Medicus | patient-derived xenograft | personalized therapy
Journal Article